Finance

Lists
QGEN:NYSE
Qiagen NV
45,44 $
+0,33%
(+0,15) 1D
45,44 $
0,00% (0,00)
After hours
Closed: 13 қаз., 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QGEN...
Open
45,77 $
High
45,79 $
Low
44,97 $
Mkt. cap
9,38 млрд
Avg. vol.
2,06 млн
Volume
1,44 млн
Dividend
0,77%
Quarterly dividend
0,09 $
Ex-dividend date
2026 ж. 07 шіл.
P/E ratio
23,38
52-wk high
57,82 $
52-wk low
32,53 $
EPS
1,94 $
Beta
0,61
Shares outstanding
206,08 млн
No. of employees
6 мың
Open
45,77 $
High
45,79 $
Low
44,97 $
Mkt. cap
9,38 млрд
Avg. vol.
2,06 млн
Volume
1,44 млн
Dividend
0,77%
Quarterly dividend
0,09 $
Ex-dividend date
2026 ж. 07 шіл.
P/E ratio
23,38
52-wk high
57,82 $
52-wk low
32,53 $
EPS
1,94 $
Beta
0,61
Shares outstanding
206,08 млн
No. of employees
6 мың
News stories
From web sources and news partners
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5,5 мың
Founded1984 ж. 29 қар.
HeadquartersVenlo, Limburg, Нидерланд
Sector-
Websiteqiagen.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
2026 ж. 06 там.
Fiscal period
Q2 2026
0,62 $ / 0,60 $
+3,45%beat
Revenue / Est. (USD)
535,04 млн / 527,46 млн
+1,44%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
532,58 млн
540,42 млн
492,32 млн
535,04 млн
Cost of goods sold
187,78 млн
173,92 млн
168,83 млн
181,97 млн
Cost of revenue
187,78 млн
173,92 млн
168,83 млн
181,97 млн
Research and development expenses
48,75 млн
47,24 млн
48,26 млн
50,43 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,11 млн
153,88 млн
142,39 млн
146,77 млн
Operating expense
207,51 млн
218,30 млн
206,24 млн
212,22 млн
Total operating expenses
395,29 млн
392,22 млн
375,06 млн
394,19 млн
Operating income
137,29 млн
148,20 млн
117,26 млн
140,85 млн
Other non operating income
-89,00 мың
-133,00 м.
193,00 м.
-35,00 мың
EBT including unusual items
134,73 млн
109,17 млн
85,83 млн
132,10 млн
EBT excluding unusual items
142,86 млн
157,94 млн
118,66 млн
140,05 млн
Income tax expense
4,68 млн
1,34 млн
17,79 млн
28,70 млн
Effective tax rate
3,48%
1,23%
20,72%
21,73%
Other operating expenses
-
-
-
-
Net income
130,04 млн
107,83 млн
68,04 млн
103,40 млн
Net profit margin
24,42%
19,95%
13,82%
19,33%
Earnings per share
-
0,62
0,54
0,62
Interest and investment income
15,07 млн
20,00 млн
10,56 млн
9,36 млн
Interest expense
-8,22 млн
-10,14 млн
-11,05 млн
-10,02 млн
Net interest expenses
6,85 млн
9,86 млн
-489,00 м.
-661,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
188,26 млн
179,60 млн
168,47 млн
191,40 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары